Zacks Investment Research Lowers Glanbia Plc ADR (GLAPY) to Sell
Zacks Investment Research cut shares of Glanbia Plc ADR (OTC:GLAPY) from a hold rating to a sell rating in a report published on Monday morning.
According to Zacks, “Glanbia Plc engages in the manufacture and distribution of dairy and nutritional food products. Its operating segments include Glanbia Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures and Associates. Glanbia Performance Nutrition segment comprises of performance nutrition products under the Optimum Nutrition, BSN, Isopure, Nutramino and ABB brands. Global Ingredients segment includes American-style cheddar cheese, micro-nutrient premixes and dairy and non-dairy nutritional solutions. Dairy Ireland segment consists of consumer products and agribusiness. Joint Ventures and Associates segment covers Glanbia Ingredients Ireland, Glanbia Cheese and Southwest Cheese. Glanbia Plc is headquartered in Kilkenny, Ireland. “
Glanbia Plc ADR (GLAPY) opened at 94.45 on Monday. The stock’s 50 day moving average is $99.69 and its 200-day moving average is $99.55. Glanbia Plc ADR has a 12 month low of $80.15 and a 12 month high of $101.75. The company has a market capitalization of $5.57 billion and a PE ratio of 21.44.
About Glanbia Plc ADR
Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company’s Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Glanbia Plc ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia Plc ADR and related stocks with our FREE daily email newsletter.